DrugPatentWatch Database Preview
Profile for United States of America Patent: 2015111904
US Patent Family Members and Approved Drugs for United States of America Patent: 2015111904
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 15, 2030 | Novartis Pharms Corp | TAFINLAR | dabrafenib mesylate |
➤ Sign Up | Oct 15, 2030 | Novartis Pharms Corp | MEKINIST | trametinib dimethyl sulfoxide |
➤ Sign Up | Oct 15, 2030 | Novartis Pharms Corp | TAFINLAR | dabrafenib mesylate |
➤ Sign Up | Oct 15, 2030 | Novartis Pharms Corp | MEKINIST | trametinib dimethyl sulfoxide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |